Genextra S.p.A.
10% owner at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $389M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Aug 17, 2020
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INC10% owner
Sales by reason
0
Routine
5
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 17, 2020Unusual
Sold 27.3% of their holdings
$71.2M1.5M shares at $47.50
- May 13, 2020Plan not stated
Sold 9.8% of their holdings
$50.4M595,578 shares at $84.60
- Nov 29, 2018Plan not stated
Sold 11% of their holdings
$78.8M750,000 shares at $105.07
- Apr 10, 2014Plan not stated
Sold 5.1% of their holdings
$111M349,318 shares at $317.71
- Oct 21, 2013Plan not stated
Sold 2.1% of their holdings
$7.8M124,912 shares at $62.50
- Oct 15, 2013Plan not stated
Sold 15.6% of their holdings
$70.2M1.1M shares at $62.50
6 of 6
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | Aug 17, 2020 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 1.5M | $47.50 | $71.2M | 4M | SEC |
| May 13, 2020 | May 15, 2020 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 595,578 | $84.60 | $50.4M | 5.5M | SEC |
| Nov 29, 2018 | Dec 3, 2018 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 750,000 | $105.07 | $78.8M | 6.1M | SEC |
| Apr 9, 2018 | Apr 9, 2018 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Bought | 390,625 | $64.00 | $25M | 6.8M | SEC |
| Apr 10, 2014 | Apr 11, 2014 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Exercised or settledWarrant to Purchase Common Stock | 865,381 | 0 | SEC | ||
| Apr 10, 2014 | Apr 11, 2014 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Exercised options | 865,381 | $10.40 | $9M | 6.5M | SEC |
| Apr 10, 2014 | Apr 11, 2014 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 349,318 | $317.71 | $111M | 6.5M | SEC |
| Oct 21, 2013 | Oct 23, 2013 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 124,912 | $62.50 | $7.8M | 5.9M | SEC |
| Oct 15, 2013 | Oct 17, 2013 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Sold | 1.1M | $62.50 | $70.2M | 6.1M | SEC |
| Oct 16, 2012 | Oct 16, 2012 | INTERCEPT PHARMACEUTICALS INC | 10% owner | ConvertedSeries A Preferred Stock | 32.3M | 0 | SEC | ||
| Oct 16, 2012 | Oct 16, 2012 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Converted | 5.6M | 7.2M | SEC |
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | Aug 17, 2020 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 1.5M | $71.2M | 27.3% | Unusual | SEC |
| May 13, 2020 | May 15, 2020 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 595,578 | $50.4M | 9.8% | Plan not stated | SEC |
| Nov 29, 2018 | Dec 3, 2018 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 750,000 | $78.8M | 11.0% | Plan not stated | SEC |
| Apr 10, 2014 | Apr 11, 2014 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 349,318 | $111M | 5.1% | Plan not stated | SEC |
| Oct 21, 2013 | Oct 23, 2013 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 124,912 | $7.8M | 2.1% | Plan not stated | SEC |
| Oct 15, 2013 | Oct 17, 2013 | INTERCEPT PHARMACEUTICALS INC | 10% owner | Form 4 sale | 1.1M | $70.2M | 15.6% | Plan not stated | SEC |